Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Inhibitor SMADs in Stage 3 Grade B Periodontitis Before and After Periodontal Treatment

NCT04846166 is registered in ClinicalTrials.gov with Bulent Ecevit University as lead sponsor.

NCT NCT04846166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04846166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Inhibitor SMADs in Stage 3 Grade B Periodontitis Before and After Periodontal Treatment
Lead sponsor
Bulent Ecevit University
Phase
Observational
Overall status
Completed
Start date
August 1, 2019
Completion date
March 1, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis, treatment adherence